TransThera Sciences Sets Hong Kong IPO at HKD13.15 Per Share
CompanyDeals

TransThera Sciences Sets Hong Kong IPO at HKD13.15 Per Share

BeOne Medicines Wins FDA Approval for Brukinsa Tablet Across All Five Indications
CompanyDrug

BeOne Medicines Wins FDA Approval for Brukinsa Tablet Across All Five Indications

Gene Solutions Partners with Topgen Biopharm to Advance Precision Oncology in Asia
CompanyDeals

Gene Solutions Partners with Topgen Biopharm to Advance Precision Oncology in Asia

Suzhou's MEI Medical Secures RMB 100M Funding for ePTFE Innovation
CompanyDeals

Suzhou’s MEI Medical Secures RMB 100M Funding for ePTFE Innovation

BMS Reports Positive POETYK PsA-1 Results for Sotyktu in Psoriatic Arthritis
CompanyDrug

BMS Reports Positive POETYK PsA-1 Results for Sotyktu in Psoriatic Arthritis

Lilly Launches Mounjaro Multi-Dose Pen in China for Diabetes and Weight Management
CompanyDrug

Lilly Launches Mounjaro Multi-Dose Pen in China for Diabetes and Weight Management

XtalPi Acquires Liverpool ChiroChem to Boost AI-Driven Drug Discovery
CompanyDeals

XtalPi Acquires Liverpool ChiroChem to Boost AI-Driven Drug Discovery

Shandong Boan Partners with Shanghai Pharma for BA5101 Diabetes Drug
CompanyDeals

Shandong Boan Partners with Shanghai Pharma for BA5101 Diabetes Drug

GCCF and CTTQ Explore Collaboration to Expand Innovative Drug Access in Hong Kong
CompanyDeals

GCCF and CTTQ Explore Collaboration to Expand Innovative Drug Access in Hong Kong

ImmVira Commences Phase II Trial for MVR-T3011 in High-Risk NMIBC
CompanyDrug

ImmVira Commences Phase II Trial for MVR-T3011 in High-Risk NMIBC

Escugen Partners with SovranBio to Accelerate Development of Antibody-Drug Conjugates
CompanyDeals

Escugen Partners with SovranBio to Accelerate Development of Antibody-Drug Conjugates

Varian Medical Systems Secures NMPA Approval for Ethos 2.0 AI Radiotherapy Platform
CompanyMedical Device

Varian Medical Systems Secures NMPA Approval for Ethos 2.0 AI Radiotherapy Platform